Clinical Trial Update: Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant PD-1 trial in newly diagnosed glioblastoma is being conducted, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Glioblastoma | Phase 2 | Status: UNKNOWN